Clinical Trial Update: Innoventric Trillium™ Stent Graft First-in-Human (FIH) Study [NA]

View source ↗

Summary

First-in-human update for Innoventric's Trillium Stent Graft in tricuspid regurgitation; the study is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tricuspid Regurgitation

Drugs mentioned

• Trillium Stent Graft

Snippet

Sponsor: Innoventric LTD | Conditions: Tricuspid Regurgitation | NA | Status: ACTIVE_NOT_RECRUITING